Dr. Victor Levin, founding member of the Society of Neuro-Oncology, joins Nuevozen' Medical Advisory Board
illi News/10037625

SAN FRANCISCO - illiNews -- Nuevozen a healthcare Artificial Intelligence company developing patient risk assessment and diagnostic solutions for cancer and other serious diseases, is pleased to announce the addition of Dr. Victor Levin, a leading Neuro Oncologist in the world, to the company's medical advisory board.

Currently, Dr. Levin is a Neuro-Oncology Physician in the Department of Neurosurgery and Neuroscience, Kaiser Permanente Medical Center, Redwood City. He is also Professor Emeritus, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center and Clinical Professor, Department of Neurosurgery, at UCSF School of Medicine. He built and chaired the world-renowned Neuro-Oncology program at the University of Texas M. D. Anderson Cancer Center.

More on illi News

• A New Era in Healthcare Marketing
• Chicago: Mayor Brandon Johnson Signs 'Right to Protest' Executive Order
• Sloan's Lake Dental Launches New Website to Enhance Patient Experience and Access to Modern Dental Care
• Only 3 Weeks Left till the Start of the OpenSSL Conference 2025
• InventHelp Inventor Develops Portable Sit-On-Scale (CLR-320)

I am deeply honored and excited to have Dr. Levin, one of the leading experts in the field of neuro-oncology, join our advisory board," stated Karan Aujla, Nuevozen' co-founder and CEO. "I look forward to working with Dr Levin to leverage his knowledge and expertise and his passion for improving patient outcome to help our team identify and develop clinical use cases of AI including volumetric analysis of infiltrative CNS tumors seen with MRI".

"I'm excited to join Nuevozen' advisory board and look forward to helping guide the company as they continue to develop their Artificial Intelligence technology," said Dr. Victor Levin. "I believe that Artificial Intelligence has the potential to improve the diagnosis of infiltrative CNS tumors and metastases and to quantify benefit of new drug therapies and other treatments for CNS tumors"

Dr. Levin founded the Society for Neuro-Oncology in 1995 and served as its first president in 1996. He has published nearly 400 peer-reviewed articles, chapters, editorials, and books including the multidisciplinary textbook, Cancer in the Nervous System. In his career, Dr. Levin received numerous awards including the Anne and Jason Farber Award for Neuro-Oncology, Gold Medal Award for Extraordinary Achievement (Society for Neuro-Oncology).  He has also been listed in The Best Doctors in America, America's Top Doctors in Cancer, and America's Top Doctors for many years.

More on illi News

• ENTOUCH Completes $50 million Funding Round
• Teaming Agreement with Emtel Energy USA to Advance Thin-Film PV Energy Storage Capabilities; NASA agreements for Solar Space Tech; Ascent Solar $ASTI
• Nebuvex Acknowledges Platform "Too Secure" for Anonymous Traders; Institutional Investors Disagree
• From Tokyo to Berlin: FreeTo.Chat Unites Cultures with the World's First Confession VRX — EmojiStream™
• AZETHIO Launches Multi-Million Dollar User Protection Initiative Following Unprecedented Platform Growth

About Nuevozen Corp.
Founded in 2018, Nuevozen Corp. is a privately held Healthcare AI company located in San Francisco Bay area. Nuevozen' mission is to help healthcare providers in improving quality and speed of care by utilizing artificial intelligence. For additional information go to www.Nuevozen.AI